Correlation of CD95 and soluble CD95 expression with acute rejection status of liver transplantation

Table 1 Levels of CD95 expression on CD3+cells (/molecule) and levels of sCD95, sCD95L (pg/mL) in plasma from post-transplanted AR group, post-transplanted stable group and healthy group.

	Post-transplantedstable group (n = 15)	Post-transplantedAR group (n = 15)	Healthy group (n = 15)
CD95 (/molecule)	6 848.20±1 712.96b	18 676.93±11 588.34	6 418.01±2 001.95d
sCD95 (pg/mL)	201.37±30.30b	391.88±196.00	148.83±58.25d
sCD95L (pg/mL)	279.42±79.72	226.82±132.63	254.38±96.29

^bP<0.01 vs post-transplanted stable group;

^dP<0.01 vs health group.

Table 2 CD4/CD8 ratio, the percentage of CD16+56+ cells in post-transplanted AR group, post-transplanted stable group and healthy group.

	Post-transplanted stable group (n = 15)	Post-transplanted AR group (n = 15)	Healthy group (n = 15)
CD4/CD8	1.5±0.5	1.8±0.4	1.5±0.2
CD16+56+ (%)	15.4±9.5	20.4±9.4	17.0±7.5